| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/10/2005 | US20050033042 Nucleic acids encoding recominant 56 and 82 kda antigens fromn gametocytes of eimeria maxima and their uses |
| 02/10/2005 | US20050033031 Methods for humanizing rabbit monoclonal antibodies |
| 02/10/2005 | US20050033019 Nucleotide sequence coding for a modified protein of interest, expression vector and method for obtaining same |
| 02/10/2005 | US20050033018 Receptors and membrane-associated proteins |
| 02/10/2005 | US20050033017 Nucleotide sequences coding receptor for advanced glycation endproducts (RAGE) for identifying modulators for treatment and prevention of cell proliferative and cardiovascular disorders |
| 02/10/2005 | US20050032834 Administering a chloroquine compound as an anticarcinogenic, antiischemic, anticholesterol, or anxiolytic agent |
| 02/10/2005 | US20050032702 Medicinal product and method for treatment of conditions affecting neural stem cells or progenitor cells |
| 02/10/2005 | US20050032693 Novel polypeptides, their nucleic acids, and methods for their use in angiogenesis and vascularization |
| 02/10/2005 | US20050032223 Generating site directed DNA breaks in transformed cells via expression of heterologous endonuclease; bioreactor for generating exogenous proteins; gene therapy |
| 02/10/2005 | US20050032220 Amplifiable adeno-associated virus (AAV) packaging cassettes for the production of recombinant AAV vectors |
| 02/10/2005 | US20050032218 Using module comprising hollow fiber matrix to propagate and isolate preferential stem cell tissues; tissue engineering and repair; regenerative medicine |
| 02/10/2005 | US20050032217 Transforming lymphocytes with vector comprising gene sequences which code cytolethal distending toxin (cdt), leukotoxins and heat shock protein and generating regulatory cell which can be used to treat and/or prevent transplant rejection, autoimmune and inflammatory diseases; immunotherapy |
| 02/10/2005 | US20050032213 Expression vector comprising polynucleotide which codes conditionally-inducible oncogene operably linked to enhancer of a nestin intron for use in prevention and treatment of disease associated with cell loss and/or damage |
| 02/10/2005 | US20050032212 Using pressurization and depressurization to increase permebility of cel wall; cell transformation and exogenous gene transfer |
| 02/10/2005 | US20050032211 Cell/tissue culturing device, system and method |
| 02/10/2005 | US20050032210 Generating modified neuronal cells directed for use in treatment of graft rejection, graft-versus-host, autoimmune and allergic diseases |
| 02/10/2005 | US20050032209 Regeneration and repair of neural tissue using postpartum-derived cells |
| 02/10/2005 | US20050032208 Materials and methods to produce stem cells |
| 02/10/2005 | US20050032207 Method for isolating, culturing and differentiating intestinal stem cells for therapeutic use |
| 02/10/2005 | US20050032206 Apparatus for culturing organism and method of culturing organism |
| 02/10/2005 | US20050032205 In vitro cell culture employing a fibrin network in a flexible gas permeable container |
| 02/10/2005 | US20050032201 Method for selectively separating blood cells by using lectin |
| 02/10/2005 | US20050032185 3-phosphoinositide-dependent protein kinase that phosphorylates and activates protein kinase B alpha; drug target for cancer; drug screening for enzyme inhibitors as anticancer agents |
| 02/10/2005 | US20050032174 Multimeric protein for use in the treatment and prevention of infection and bleeding disorders |
| 02/10/2005 | US20050032172 Expression vector comprising nucleotide sequences coding tumor necrosis factor (FTHMA-) and/or axon guidance receptor (T85) for use in identifying modulators for prevention and/or treatment of cell proliferative or neurological disorders |
| 02/10/2005 | US20050032170 Expression vector comprising nucleotide sequences coding native sequence-4 (NS4) for use in identifying modulators for treatment and prevention of obesity, cachexia and anorexia |
| 02/10/2005 | US20050032168 17 human secreted proteins |
| 02/10/2005 | US20050032161 Novel xanthine phosphoribosyl transferase |
| 02/10/2005 | US20050032160 Cell-based therapies for diabetes mellitus and other glucose intolerant states |
| 02/10/2005 | US20050032158 Using novel g-protein coupled taste receptor (T1R2) as tools in identifying modulators to use as additives which enhance sweetness of foods consumed by animal and humans |
| 02/10/2005 | US20050032155 Expression vector comprising nucleotide sequences coding defective receptor protein for use as model in treatment and prevention of convulsive disorders |
| 02/10/2005 | US20050032146 Tssk4: a human testis specific serine/threonine kinase |
| 02/10/2005 | US20050032136 Method for identifying endocrine disruptors and kit for carrying out the same |
| 02/10/2005 | US20050032127 Using microfluidics to separate and identify cells expressing preferential products; reporter gene diagnostics; fluorescent microscopy |
| 02/10/2005 | US20050032125 Constitutively translocating cell line |
| 02/10/2005 | US20050032122 Optimizing culture medium for CD34<+> hematopoietic cell expansion |
| 02/10/2005 | US20050032085 Novel chromophores/fluorophores and methods for using the same |
| 02/10/2005 | US20050032078 Methods for the detection, analysis and isolation of nascent proteins |
| 02/10/2005 | US20050032068 Oligomers hybridize with each other, one of which includes peptide nucleic acid or mimic, a morpholino nucleic acid, hexose sugar with amide linkage, cyclohexenyl nucleic acid or an acyclic backbone modification; gene expression inhibition |
| 02/10/2005 | US20050032064 Method and device for identifying substances capable of modulating adipocyte differentiation |
| 02/10/2005 | US20050032059 Genetically modified hydrolase comprising enhanced activity for use in hydrolysis of starch to glucose; textile treatment; preparation of animal feeds |
| 02/10/2005 | US20050032054 Screening for novel bioactivities |
| 02/10/2005 | US20050032046 Using immortalized cells which express viral cell surface receptor as diagnostic models for screening viricidal agents; drug screening |
| 02/10/2005 | US20050032041 Using viral protein as diagnostic indicator of infection in grapes; immunodiagnostics |
| 02/10/2005 | US20050032031 Method for eliminating fragile cells from stored cells |
| 02/10/2005 | US20050031669 a biodegradable polymer (glycolic acid-lactic acid copolymer) with a hydrophobic or hydrophobically enhanced drug; sustained release ocular implants; vision defects |
| 02/10/2005 | US20050031642 Clonal lentogenic oncolytic strain of Newcastle Disease Virus and hemaglutinin-neuraminidase (HN) gene |
| 02/10/2005 | US20050031628 Chimeric antigens for breaking host tolerance to foreign antigens |
| 02/10/2005 | US20050031624 Monoclonal antibodies to human immunodeficiency virus and uses thereof |
| 02/10/2005 | US20050031623 Blot analysis of urine/serum; proteoglycan-like domains; oncogenes; hybridomas |
| 02/10/2005 | US20050031617 Antibodies specific for cancer associated antigen SM5-1 and uses thereof |
| 02/10/2005 | US20050031612 Cytotoxic t lymphocytes; human leukocyte antigen; non-hematopoietic cells; graft versus host disease |
| 02/10/2005 | US20050031600 Cardiac function by mesenchymal stem cell transplantation |
| 02/10/2005 | US20050031599 Method of isolating retinal stem cells and inducing retinal stem cells to produce retinal cells; retinal stem cell and retinal cell culture systems may be used for toxicological assays, for isolating genes involved in retinal differentiation or for developing tumor cell lines |
| 02/10/2005 | US20050031598 Engineering three-dimensional tissue structures using differentiating embryonic stem cells |
| 02/10/2005 | US20050031595 Ex-vivo expanding a population of stem cells, while inhibiting differentiation of the stem cells using a transition metal compound that chelates copper such as tetraethylenepentamine |
| 02/10/2005 | US20050031583 Uses of opg to modulate immune responses |
| 02/10/2005 | US20050031578 Comprising a naturally occurring polyol and a biocompatible, synthetic polyol and isocyanate which react to form a polyesterurethane; composition promotes bone growth when positioned in the vicinity of a bone of a mammal |
| 02/10/2005 | DE10333406A1 T-regulatorische-Zellen enthaltend Galectine zur Therapie und Diagnose von Erkrankungen T-regulatory cells containing galectins for the therapy and diagnosis of diseases |
| 02/10/2005 | DE10297513T5 In vitro Herstellung von dendritischen Zellen aus CD14+ Monocyten In vitro production of dendritic cells from CD14 + monocytes |
| 02/10/2005 | CA2793046A1 Method for the isolation and expansion of cardiac stem cells from biopsy |
| 02/10/2005 | CA2758178A1 Human skin equivalents expressing exogenous polypeptides |
| 02/10/2005 | CA2534378A1 Method for the isolation and expansion of cardiac stem cells from biopsy |
| 02/10/2005 | CA2534377A1 Method for immunotherapy of tumors |
| 02/10/2005 | CA2534356A1 Scaffold-free self-organized 3d synthetic tissue |
| 02/10/2005 | CA2534123A1 Extended primary retinal cell culture and stress models, and methods of use |
| 02/10/2005 | CA2534077A1 Antibodies and methods for generating genetically altered antibodies with enhanced effector function |
| 02/10/2005 | CA2533941A1 Novel nucleic acids from sesame plants |
| 02/10/2005 | CA2533512A1 Antagonists and agonists of ldcam and methods of use |
| 02/10/2005 | CA2532970A1 Cell cultivation and breeding method |
| 02/10/2005 | CA2531684A1 Binding molecules against sars-coronavirus and uses thereof |
| 02/10/2005 | CA2531320A1 Reversibly immortalised olfactory ensheathing glia and their use to promote neuronal regeneration |
| 02/10/2005 | CA2531231A1 Uranium-chelating peptides and uses thereof |
| 02/10/2005 | CA2531093A1 Support for immobilising catalytically active units |
| 02/10/2005 | CA2530630A1 Systems and methods for separating and concentrating regenerative cells from tissue |
| 02/10/2005 | CA2530172A1 Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof |
| 02/10/2005 | CA2529954A1 Methods of using adipose tissue-derived cells in augmenting autologous fat transfer |
| 02/10/2005 | CA2521284A1 Novel glyphosate-n-acetyltransferase (gat) genes |
| 02/09/2005 | EP1505153A1 Nucleic acid sequence comprising the rna packaging signal of a group 1 coronavirus and the applications thereof |
| 02/09/2005 | EP1505075A1 Antibody to human insulin-like growth factor |
| 02/09/2005 | EP1504764A1 Treatment of liver fibrosis with antagonists of alpha V beta 6 integrin |
| 02/09/2005 | EP1504108A2 Viral vector |
| 02/09/2005 | EP1504107A1 Recombinant fowlpox virus |
| 02/09/2005 | EP1504105A1 Wound-inducible expression in plants |
| 02/09/2005 | EP1504093A2 Rna detection enzymes |
| 02/09/2005 | EP1504091A2 Error-prone dna polymerase i mutants and methods for targeted random mutagenesis in continuous culture using error-prone dna polymerase i mutants |
| 02/09/2005 | EP1504090A2 A chimeric reverse transcriptase and methods for identifying telomerase inhibitors |
| 02/09/2005 | EP1504087A2 Bioartificial skin |
| 02/09/2005 | EP1504086A2 Control of es cell self renewal and lineage specification, and medium therefor |
| 02/09/2005 | EP1504030A2 Constitutively translocating cell line |
| 02/09/2005 | EP1504027A2 Adipocyte complement related protein zacrp8 |
| 02/09/2005 | EP1504017A2 Mutant chromophores/fluorophores and methods for making and using the same |
| 02/09/2005 | EP1504016A2 Use of spliceosome mediated rna trans-splicing to confer cell selective replication to adenoviruses |
| 02/09/2005 | EP1503985A2 Polypeptides and biosynthetic pathways |
| 02/09/2005 | EP1503819A1 System and method for forming a non-ablative cardiac conduction block |
| 02/09/2005 | EP1503789A2 Vascularization enhanced graft constructs |
| 02/09/2005 | EP1503767A2 Compositions and methods for treatment of vitamin d deficiency |
| 02/09/2005 | EP1503745A2 15625 receptor, a novel g-protein coupled receptor |
| 02/09/2005 | EP1503735A2 A direct cellular energy delivery system |
| 02/09/2005 | EP1503716A1 System and method for treating cardiac arrhythmias with fibroblast cells |